GO
Loading...

Private Equity

More

  • Top Chinese PE firm: Sectors we're bullish on  Sunday, 30 Nov 2014 | 5:49 PM ET

    Despite slowing growth in China, Wang Chao Yong, Chairman and CEO at China Equity Group, explains why he's still positive on domestic prospects.

  • Tiger Global, which manages roughly $14.5 billion in hedge fund and private equity portfolios, wrote to investors in a Nov. 25 letter seen by Reuters, that it wants to raise as much as $1 billion in new capital at its Tiger Global Long Opportunities fund. Co-founded by Chase Coleman, Tiger Global was seeded by hedge fund industry veteran Julian Robertson and ranks...

  • Nov 25- The U.S. Justice Department is investigating allegations that an employee of HSBC Holdings Plc leaked confidential client information to a major hedge fund, the Wall Street Journal reported, citing people with knowledge of the matter. The alleged leak is believed to have taken place in March 2010, when HSBC was advising British insurer Prudential Plc on...

  • Nov 21- Dow Chemical Co said it would add four independent directors to its board as part of an agreement with Daniel Loeb's hedge fund, Third Point LLC, avoiding a proxy battle. The $17.5 billion hedge fund was considering a proxy contest after negotiations with Dow over board seats broke down, Reuters had reported on Thursday. The fund is known for pushing...

  • Nov 20- Renowned oil trader Andy Hall's hedge fund Astenbeck Capital Management had a 5 percent loss in October, after performing reasonably well the prior two months amid tumbling oil prices, according to a letter to investors from Hall. Westport, Connecticut- based Astenbeck, which manages approximately $3 billion, is now up 6 percent on the year, Hall said in the...

  • Greek drama: Telecom focus of bloody PE fight Thursday, 20 Nov 2014 | 10:50 AM ET
    David Bonderman, founding partner of TPG Capital

    SPQR has won a big judgment in a long-running legal saga that accuses TPG and Apax of bankrupting a Greek telecom.

  • Nov 19- Hedge fund Livermore Partners is pushing for change at U.S. staffing services provider Volt Information Sciences Inc, setting the stage for a potential proxy battle if the company does not act on its demands. It also wants it to sell non-core assets and buy back stock, said David Neuhauser, Livermore's managing director. Volt's share price has...

  • Why mainland PE firms are investing abroad  Tuesday, 18 Nov 2014 | 8:45 PM ET

    Shan Weijian, Group Chairman & CEO at PAG, outlines the factors that are driving Chinese private equity firms to invest overseas.

  • Are US stocks expensive? Motley Fool says no  Monday, 17 Nov 2014 | 10:09 PM ET

    David Kuo, CEO at The Motley Fool, explains why he disagrees with JP Morgan's comment that U.S. equities are "outright expensive" compared with European stocks.

  • Private equity bets on 'revolution'—in oil and gas Monday, 17 Nov 2014 | 2:23 PM ET
    A derrick hand for Raven Drilling, works on an oil rig drilling into the Bakken shale formation outside Watford City, North Dakota.

    Private equity is betting that gas and oil—notrenewables like wind and solar—will continue to dominate as energy sources in 25 years.

  • LONDON, Nov 17- Hedge funds have been badly wrong-footed by the slide in oil prices over the past five months, and by trying to turn their positions around have accelerated the rout. By the middle of June, hedge funds had a net long position in WTI-linked futures and options contracts equivalent to almost 413 million barrels of crude oil, according to the U.S....

  • BOSTON, Nov 14- Some of the hedge fund industry's most respected firms made bigger bets on a wide swatch of energy companies during the third quarter only to watch the stocks get pummeled by falling crude oil prices. Robert Citrone's Discovery Capital Management raised its holding in Texas oil driller Diamondback Energy by 20 percent to own 1.4 million shares...

  • NEW YORK, Nov 14- Hedge funds scooped up shares of China's Alibaba Group Holding in the third quarter, making the e-commerce giant one of the most commonly bought stocks among some of the biggest U.S. investors, according to regulatory filings on Friday. Among the institutional investors that took new stakes in Alibaba were Soros Fund Management, the hedge fund...

  • PE looks to cash in on cannabis  Friday, 14 Nov 2014 | 4:45 PM ET

    CNBC's Kate Rogers catches up with one of the only private equity firms gambling on the pot business.

  • NEW YORK, Nov 14- Hedge funds scooped up shares of Chinese company Alibaba Group Holding in the third quarter, making the e-commerce giant one of the most commonly bought stocks among some of the country's biggest investors, according to regulatory filings on Friday. Among the institutional investors that took new stakes in Alibaba were Jana Partners, the $11...

  • BOSTON, Nov 13- Hedge fund Third Point is considering launching a proxy contest at Dow Chemical Co after negotiations over board seats with the largest U.S. chemical company broke down on Thursday, two sources familiar with the talks said. Third Point, one of Dow's biggest investors with a 2 percent stake, had been talking to the company for months and was told last...

  • HONG KONG, Nov 14- When the landmark Hong Kong- Shanghai equity link debuts on Monday, a class of investors that China has kept at arm's length until now- hedge funds- are expected to plunge into mainland shares. Beijing aims to control inflows and volatility hikes by imposing a daily quota of 13 billion yuan plus restrictions on short selling. "The Chinese government...

  • BOSTON, Nov 13- Hedge fund Marcato Capital Management has bought a 1.6 percent stake in the Bank of New York Mellon, becoming the second prominent activist investor in recent months to disclose a position in the world's largest custody bank, according to a regulatory filing. San Francisco- based Marcato's stake is valued at $688 million, making it the biggest...

  • ACTIVIST HEDGE FUND MARCATO CAPITAL MANAGEMENT TAKES STAKE IN BANK OF NEW YORK MELLON- REGULATORY FILING.

  • But a series of failed deals, including the collapse of a $55 billion tie-up between UK drugmaker Shire and U.S. peer AbbVie, has led to losses for some of the world's biggest proponents of the strategy, with investors pulling out $3.3 billion in the last two months alone. "The AbbVie/ Shire break, in particular, has led to a far reaching de-risking exercise for many...